• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Laura Lorenzetti

Stay informed with Laura Lorenzetti’s coverage and analysis.

Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
HealthMylan Reaches $7.2 Billion Deal for Meda
By Laura LorenzettiFebruary 10, 2016
US-BUSINESS-AVIATION-BOEING
FinanceFortune 500 Companies Are Getting Billions From Federal Small Business Contracts
By Laura LorenzettiFebruary 10, 2016
Fortune Global Forum 2015
TechHow to Offend 1 Billion Indians With 1 Tweet
By Laura LorenzettiFebruary 10, 2016
Barry Diller, chairman and senior executive of IAC/InterActiveCorp, speaks at the Bloomberg Markets Most Influential Summit 2015 in New York, U.S., on Tuesday, Oct. 6, 2015. The summit brings together the bankers, policymakers, money managers and big thinkers who matter most for a day of discussion about the macroeconomic trends and global forces shaping investment strategy. Photographer: Chris Goodney/Bloomberg *** Local Caption ***Barry Diller
TechBarry Diller Is Selling PriceRunner
By Laura LorenzettiFebruary 10, 2016
US-ECONOMY-FINANCE-CONGRESS-YELLEN
FinanceGoogle Cars and Yellen Heads to the Hill—5 Things to Know Today
By Laura LorenzettiFebruary 10, 2016
Number of People With Health Insurance Highest in 20 Years
HealthNumber of People With Health Insurance Highest in 20 Years
By Laura LorenzettiFebruary 9, 2016
CVS Caremark Changes Its Name To CVS Health
HealthCVS Health’s Drug Sales Are Booming
By Laura LorenzettiFebruary 9, 2016
New Hampshire Prepares For Country's First Primary In 2016 Election
LeadershipJapan’s Nikkei and the New Hampshire Primary—5 Things to Know Today
By Laura Lorenzetti and Ian MountFebruary 9, 2016
KFC Debuting Yet Another New Colonel During the Super Bowl
Arts & EntertainmentKFC Debuting Yet Another New Colonel During the Super Bowl
By Laura LorenzettiFebruary 4, 2016
NASA's Orion Spacecraft Launches Unmanned Test Flight
TechCongress Says NASA’s Mars Initiative Needs a Better Plan
By Laura LorenzettiFebruary 4, 2016
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
HealthMartin Shkreli Calls U.S. Lawmakers ‘Imbeciles’
By Laura LorenzettiFebruary 4, 2016
House Oversight Hearing On Prescription Drug Price Increases
HealthHow Martin Shkreli Is ‘Trashing’ the Pharma Industry
By Laura LorenzettiFebruary 4, 2016
CNBC Events - Season 2015
LeadershipThis Industry Titan May Move His Support From Jeb to Rubio
By Laura LorenzettiFebruary 3, 2016
Here’s What the U.S. Is Doing to Fight Zika Virus at Home
HealthHere’s What the U.S. Is Doing to Fight Zika Virus at Home
By Laura LorenzettiFebruary 3, 2016
Joe Burr - Washington, DC
RetailThere’s a New Way to Order Dominos This Super Bowl Sunday
By Laura LorenzettiFebruary 3, 2016
1...
  • 11
  • 12
  • 13
  • 14
  • 15
...73
Most Popular
Success
CEO of $20 billion AI firm Perplexity says the secret to success is ‘sleeping with that fear’ that your competitor will steal your ideaplaceholder alt text
By Preston ForeJune 13, 2026
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Economy
Boomers actually do hold most of the wealth and power. So why do they call it 'whiny' to point that out?placeholder alt text
By Nick LichtenbergJune 14, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.